| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972962 | The Journal of Heart and Lung Transplantation | 2006 | 6 Pages |
Abstract
Based on our findings, we believe that clinical trials should be designed to test treatments based on predominant rejection patterns and that end-points for trials should be defined by number of biopsies positive for either CR or AMR. This approach may lead to improved patient and allograft survival.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Abdallah G. MD, Josef MD, Dale G. MD, Gregory PhD, James T. MD, Edward M. MD, James S. MD, James W. MD, PhD, M. Elizabeth H. MD,